TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Activity

818 hedge funds and large institutions have $30.6B invested in Teva Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 260 increasing their positions, 327 reducing their positions, and 82 closing their positions.

Holders
818
Holders Change
-3
Holders Change %
-0.37%
% of All Funds
22.06%
Holding in Top 10
47
Holding in Top 10 Change
-23
Holding in Top 10 Change %
-32.86%
% of All Funds
1.27%
New
87
Increased
260
Reduced
327
Closed
82
Calls
$692M
Puts
$508M
Net Calls
+$184M
Net Calls Change
-$184M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.84B
2
SC
2
Sculptor Capital
New York
$216M
3
GCM
3
Glenview Capital Management
New York
$168M
4
SIG
4
Senator Investment Group
New York
$136M
5
PC
5
Paulson & Co
New York
$120M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$136M
2
Capital Research Global Investors
2
Capital Research Global Investors
California
$219M
3
Franklin Resources
3
Franklin Resources
California
$2.96B
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$231M
5
Lazard Asset Management
5
Lazard Asset Management
New York
$1.04B
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.84B 64,993,668 +8,918,008 +16%
Franklin Resources
2
Franklin Resources
California
$2.96B 50,121,400 -4,925,570 -9%
Invesco
3
Invesco
Georgia
$1.25B 21,070,949 -1,045,741 -5%
Lazard Asset Management
4
Lazard Asset Management
New York
$1.04B 17,606,727 -2,496,502 -12%
WRF
5
Waddell & Reed Financial
Kansas
$1.02B 17,315,689 +74,107 +0.4%
MIP
6
Mondrian Investment Partners
United Kingdom
$620M 10,482,269 +26,709 +0.3%
BA
7
BlackRock Advisors
Delaware
$617M 10,440,711 +605,277 +6%
Barrow, Hanley, Mewhinney & Strauss
8
Barrow, Hanley, Mewhinney & Strauss
Texas
$583M 9,862,843 -327,061 -3%
Allianz Asset Management
9
Allianz Asset Management
Germany
$581M 9,837,937 -1,571,013 -14%
PC
10
PointState Capital
New York
$574M 9,705,591 -604,374 -6%
Norges Bank
11
Norges Bank
Norway
$555M 9,387,741 -1,117,967 -11%
Boston Partners
12
Boston Partners
Massachusetts
$517M 8,755,438 -238,262 -3%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$445M 7,526,464 +114,904 +2%
PI
14
Putnam Investments
Massachusetts
$417M 7,056,847 +1,915,309 +37%
Neuberger Berman Group
15
Neuberger Berman Group
New York
$360M 6,096,199 -509,959 -8%
Westfield Capital Management
16
Westfield Capital Management
Massachusetts
$346M 5,857,591 +266,720 +5%
MAA
17
Managed Account Advisors
New Jersey
$345M 5,840,397 -278,209 -5%
William Blair & Company
18
William Blair & Company
Illinois
$323M 5,467,857 -57,336 -1%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$309M 5,224,337 -476,936 -8%
EVM
20
Eaton Vance Management
Massachusetts
$288M 4,879,924 +603,720 +14%
Macquarie Group
21
Macquarie Group
Australia
$281M 4,750,757 -762,169 -14%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$271M 4,591,467 +912,758 +25%
Nordea Investment Management
23
Nordea Investment Management
Sweden
$269M 4,554,939 +65,085 +1%
JPMorgan Chase & Co
24
JPMorgan Chase & Co
New York
$268M 4,541,078 +1,074,001 +31%
HCM
25
Highfields Capital Management
Massachusetts
$264M 4,468,354 -617,551 -12%
1
2 3 4 5